OUR PRODUCTS

MOBILE APPS

GENERAL INFO

KRTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Karuna Therapeutics (KRTX) Ownership - Who owns Karuna Therapeutics?

Karuna Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical needs... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

99 High Street

Phone

+1 857 449-2244

Employees

339

Web

https://www.karunatx.com

Details

Group

Domestic Stock Funds

Fundamentals

KRTX

Capitalization

N/A

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

N/A

Revenue

N/A

ROE

N/A

Book Value

N/A

P/B Ratio

N/A

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

N/A

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

N/A

Shares Held By Institutions

N/A

Shares Outstanding - Current

N/A

Total Liabilities

N/A

Total Volume MTD

N/A

Value

N/A

Gain YTD

N/A

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for KRTX (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company, which engages in research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders.

Industry Biotechnology